 |
|
|
|
|
|
|
 |
|
 |
|
|||
 |
|
|||||
 |
 |
 |
 |
|
||
 |
|
|||||
|
||||||
 |
|
|||||
 
|
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
|
 
|
|
Press Releases ---------------------------------------------------------------- FOR IMMEDIATE RELEASE
IRIS SCHEDULES THIRD QUARTER EARNINGS ANNOUNCEMENT AND CONFERENCE CALL FOR TUESDAY, NOV. 14, 2006 CHATSWORTH, Calif., Nov. 6, 2006 — IRIS International, Inc. (NASDAQ: IRIS) announced today that it expects to file a five-day extension with the Securities and Exchange Commission (SEC) relating to the filing of its Form 10-Q for the third quarter ended September 30, 2006. The Company will request the extension because it does not expect to complete the preparation of the 10-Q by the initial filing deadline of Nov. 9 as an accelerated filer. The Company expects to announce its third quarter financial results concurrent with the 10-Q filing after market close on Tuesday, Nov. 14, 2006, and to host a conference call at 4:30 p.m. Eastern time that day. To participate in the conference call, dial 1-866-558-6338 approximately 10 minutes before the conference call is scheduled to begin. Hold for the operator and reference the IRIS International conference call. International callers should dial 213-785-2437. The conference call may also be accessed by means of a live audio Web cast on the Company's Web site at www.proiris.com, or at www.vcall.com. The audio cast will also be available for replay on both Web sites for 45 days from the date of the broadcast. For anyone who is unable to participate in the conference, access to a recording will be available for seven days following the call. Dial 1-888-203-1112 to access playback. International callers should dial 719-457-0820. The replay pass code I.D. is 7421027. The Company IRIS International, Inc. (http://www.proiris.com), based in Chatsworth, Calif., is a leader in automated urinalysis technology with systems in major medical institutions throughout the world. The Company's Sample Processing business unit (formerly the StatSpin® subsidiary) (www.statspin.com), based in Westwood, Mass., manufactures innovative centrifuges and blood analysis products. Advanced Digital Imaging Research, LLC (ADIR) (www.adires.com), based near Houston, Texas, is the Company's imaging research and development subsidiary. The IRIS Molecular Diagnostics (IMD) Subsidiary develops innovative ultra-sensitive diagnostics and sample processing products with applications in the urinalysis, oncology and infectious disease markets. |
